AZGP1 and coronary artery disorder: In our present study, we found that serum ZAG could distinguish CAD patients from controls with an AUC of 0.706, distinguish NCAD patients from controls with an AUC of 0.673, and distinguish NCAD and CAD patients from controls with an AUC of 0.692.